PMID- 28327951 OWN - NLM STAT- MEDLINE DCOM- 20180302 LR - 20220330 IS - 1569-8041 (Electronic) IS - 0923-7534 (Print) IS - 0923-7534 (Linking) VI - 28 IP - 5 DP - 2017 May 1 TI - HPV16 DNA and integration in normal and malignant epithelium: implications for the etiology of laryngeal squamous cell carcinoma. PG - 1105-1110 LID - 10.1093/annonc/mdx027 [doi] AB - BACKGROUND: Molecular evidence suggests that human papillomavirus (HPV) has a role in the etiology of oropharyngeal squamous cell carcinoma. However, the role of HPV in laryngeal squamous cell carcinoma (LSCC) is unclear. PATIENTS AND METHODS: We conducted a case-control study using tumor tissue specimens from 300 LSCC patients and vocal cord polyp specimens from 300 cancer-free controls. HPV genotype, HPV16 viral load and viral integration status, and p16 expression were determined. RESULTS: The prevalence of HPV (all types) was higher in cases than controls [21 (7.0%) versus 10 (3.3%), adjusted odds ratio (aOR) 2.37, 95% CI 1.08-5.21]. The prevalence of HPV16 was higher in cases than controls [20 (6.7%) versus 8 (2.7%), aOR 2.84, 95% CI 1.21-6.68]. The risk of LSCC associated with HPV16 DNA positivity was even higher in patients aged 55 years or younger (aOR 3.52, 95% CI 1.07-11.54), males (aOR 4.74, 95% CI 1.33-16.90), never-smokers (aOR 5.57, 95% CI 1.41-22.10), and never-drinkers (aOR 3.72, 95% CI 1.09-12.72). HPV DNA was partly or fully integrated in all 20 HPV16-positive cases but was episomal in all 8 HPV16-positive controls; however, the HPV16-positive cases and controls had similar viral loads (P = 0.28). P16 immunostaining was positive in 31 of the 300 cases (10.3%) and negative in all 300 controls. CONCLUSION: These results suggest that prior infection with HPV16 may play a role in the etiology of some LSCC. This larger case-control study will offer for the first time the possibility to address in depth the understanding of a tissue-specific role of HPV in laryngeal carcinogenesis. Further studies with larger samples are needed to confirm these findings. CI - (c) The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. FAU - Chen, X AU - Chen X AD - Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Gao, L AU - Gao L AD - Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Sturgis, E M AU - Sturgis EM AD - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA. FAU - Liang, Z AU - Liang Z AD - Department of Pathology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Zhu, Y AU - Zhu Y AD - Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Xia, X AU - Xia X AD - Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Zhu, X AU - Zhu X AD - Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Chen, X AU - Chen X AD - Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. FAU - Li, G AU - Li G AD - Department of Head and Neck Surgery, The University of Texas MD Anderson Cancer Center, Houston, USA. FAU - Gao, Z AU - Gao Z AD - Department of Otolaryngology-Head and Neck Surgery, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China. LA - eng PT - Journal Article PL - England TA - Ann Oncol JT - Annals of oncology : official journal of the European Society for Medical Oncology JID - 9007735 RN - 0 (DNA, Viral) SB - IM MH - Adult MH - Aged MH - Carcinoma, Squamous Cell/genetics/pathology/*virology MH - DNA, Viral/*genetics/isolation & purification MH - Epithelium/pathology/virology MH - Female MH - Human papillomavirus 16/*genetics/pathogenicity MH - Humans MH - Laryngeal Neoplasms/genetics/pathology/*virology MH - Male MH - Middle Aged MH - Viral Load MH - Virus Integration/genetics PMC - PMC5406756 OTO - NOTNLM OT - head and neck cancer OT - human papillomavirus OT - laryngeal cancer OT - physical status OT - risk OT - viral load EDAT- 2017/03/23 06:00 MHDA- 2018/03/03 06:00 PMCR- 2017/01/23 CRDT- 2017/03/23 06:00 PHST- 2017/03/23 06:00 [pubmed] PHST- 2018/03/03 06:00 [medline] PHST- 2017/03/23 06:00 [entrez] PHST- 2017/01/23 00:00 [pmc-release] AID - S0923-7534(19)32006-X [pii] AID - mdx027 [pii] AID - 10.1093/annonc/mdx027 [doi] PST - ppublish SO - Ann Oncol. 2017 May 1;28(5):1105-1110. doi: 10.1093/annonc/mdx027.